Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul;32(7):1168-1173.
doi: 10.1038/s41433-018-0136-x. Epub 2018 Jun 11.

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary

Imran H Yusuf  1 , Barny Foot  2 , James Galloway  3 , Michael R Ardern-Jones  4 , Sarah-Lucie Watson  5 , Cathy Yelf  6 , Michael A Burdon  7 , Paul N Bishop  8 , Andrew J Lotery  9
Affiliations
Review

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary

Imran H Yusuf et al. Eye (Lond). 2018 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
A flow diagram summarising the recommended baseline tests (a) and the recommended screening algorithm (b)
See this image and copyright information in PMC

References

    1. Imran H. Yusuf, Barny Foot, James Galloway, Michael R. Ardern-Jones, Sarah-Lucie Watson, Cathy Yelf, Michael A. Burdon, Paul N. Bishop, Andrew J. Lotery. Royal College of Ophthalmologists Guideline Development Group - Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Screening. https://www.rcophth.ac.uk/standards-publications-research/clinical-guide... Accessed 3 March 2018. - PMC - PubMed
    1. Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye. 2017;31:828–45. doi: 10.1038/eye.2016.298. - DOI - PMC - PubMed
    1. Alarcon GS, McGwin G, Bertoli AM, et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) Ann Rheum Dis. 2007;66:1168–72. doi: 10.1136/ard.2006.068676. - DOI - PMC - PubMed
    1. Yates M, Malaiya R, Stack J, Galloway JB. Hydroxychloroquine use: the potential impact of new ocular screening guidelines. Eye. 2018;32:161–2. doi: 10.1038/eye.2017.166. - DOI - PMC - PubMed
    1. Mavrikakis I, Sfikakis PP, Mavrikakis E, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology. 2003;110:1321–6. doi: 10.1016/S0161-6420(03)00409-3. - DOI - PubMed

MeSH terms